CD274 and neoplasm: The authors indicated that the proposed synergy mechanisms undermining the use of radiation therapy and PD-1/PD-L1 inhibitors occur in concordance with the modulation of the immune parameters within the tumor microenvironment including the upregulation of PD-1/PD-L1 in immune and tumor cells.